Organization | Afyon Kocatepe University

Afyon Kocatepe University Report issue

Academic/Hospital Phase 4

Founded: Afyonkarahisar Turkey (1992)

Organization Overview

First Clinical Trial

2014

NCT03966560

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2015

Timeline

NOW

Now

Alternative names

Afyon Kocatepe University Eye Clinics | Afyon Kocatepe University Hospital

Active Ingredients

Drugs in Phase 4 Trials (9)

alfuzosin (uroxatral) (1 trial)

bimatoprost (lumigan) (1 trial)

brimonidine (alphagan) (1 trial)

brinzolamide (azopt) (1 trial)

dorzolamide (trusopt) (1 trial)

latanoprost (xalatan) (1 trial)

tamsulosin (flomax) (1 trial)

timolol (blocadren) (1 trial)

travoprost (travatan) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Choroid Diseases (Phase 4)

Glaucoma (Phase 4)

Glaucoma, Open-Angle (Phase 4)

Hyperplasia (Phase 4)

Prostatic Hyperplasia (Phase 4)

Overview

Highest Phase: Phase 4
# of Trials: 2
# of Trial APIs: 9